Short Interest in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Decreases By 56.3%

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX - Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 191,600 shares, a decrease of 56.3% from the January 15th total of 438,800 shares. Based on an average trading volume of 3,170,000 shares, the short-interest ratio is presently 0.1 days. Approximately 2.4% of the shares of the company are sold short.

Cumberland Pharmaceuticals Stock Performance

Shares of CPIX stock traded up $0.51 during trading hours on Monday, reaching $5.15. 178,643 shares of the company's stock were exchanged, compared to its average volume of 4,512,980. The company has a market cap of $72.31 million, a P/E ratio of -6.69 and a beta of 0.12. The company's 50 day moving average is $2.78 and its two-hundred day moving average is $1.80. Cumberland Pharmaceuticals has a 1 year low of $1.04 and a 1 year high of $6.43. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.13 and a quick ratio of 0.99.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on Cumberland Pharmaceuticals in a research note on Friday. They set a "hold" rating for the company.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.